¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-11-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-11-04
±³À°ÀÏÀÚ : 2022-11-04
±³À°Àå¼Ò : ¼­¿ï, ÄÜ·¡µåÈ£ÅÚ(¿©Àǵµ) ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : ¼­Áö¿ø
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú»ý¸®ÇÐ, ¾à¸®ÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 26 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í *»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø), Á¤È¸¿ø ¿Ü(8¸¸¿ø), Àü°øÀÇ ¹× ±âŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)*ÇöÀåµî·Ï: Á¤È¸¿ø(8¸¸¿ø), Á¤È¸¿ø ¿Ü(10¸¸¿ø), Àü°øÀÇ ¹× ±âŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-04 Rooom A 09:45~10:00 The Association among Fat Distribution, Insulin Resistance, and Hypertension Risk  À念¿ì(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 10:00~10:15 How to Eat Wisely Our Asian Diet for Living Healthy Long Life with Less Cardiovascular Risks (CVR)  Yukio Yamori(Mukogawa Women) 
±³À°½Ã°£ 11-04 Rooom A 10:15~10:30 Visceral Fat Reduction and Improvement in BP  ±¸À¯Á¤(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 10:30~10:45 What is the Effective Treatment of Obesity in Patient with Hypertension  ÃÖÁ¾ÇÑ(°Ç±¹ÀÇ´ë) 
Åä·Ð 11-04 Rooom A 10:45~11:00 ÆгΠÅäÀÇ  Á¤Çý¹®, Á¶µ¿Çõ, Çã¶õ, Yook-Chin Chia(°æÈñÀÇ´ë, ¿¬¼¼¿øÁÖÀÇ´ë, ÇѾçÀÇ´ë, Sunway University) 
±³À°½Ã°£ 11-04 Rooom A 11:10~12:20 Young Investigator Award  ÀÓ»óÇö, ½ÅÁøÈ£(°¡Å縯ÀÇ´ë, ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 12:30~12:50 Importance of 24h BP Control for reducing CVD Risk ; The role of Edarbi  À̼÷Áø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 12:50~13:10 Intensive treatment strategy in Hypertension  Á¤Çý¹®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 13:35~13:50 Heterogeneity of Treatment Effect in Hypertension  À¯½ÂÂù(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 13:50~14:05 Novel Technology for BP Measurement  °­½ÃÇõ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 14:05~14:20 Artificial intelligence in Hypertension  Kazuomi Kario(Jichi Medical University School of Medicine) 
±³À°½Ã°£ 11-04 Rooom A 14:20~14:35 Digital Therapeutics: BP Management in the Digital Era  ½Åµ¿È£(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-04 Rooom A 14:35~14:50 ÆгΠÅäÀÇ  ±è´ëÈñ, ¹ÚÁعü, À̼ö¿¬(¿ï»êÀÇ´ë, ÀÌÈ­ÀÇ´ë, ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-04 Rooom A 15:00~15:15 Global Trends in Hypertension Prevalence and Progress in Treatment and Control  Bin Zhou(Imperial College London) 
±³À°½Ã°£ 11-04 Rooom A 15:15~15:30 Epidemiology of Hypertension in China  Jiguang Wang(Shanghai Jiaotong University) 
±³À°½Ã°£ 11-04 Rooom A 15:30~15:45 Trends of Hypertension Prevalence and Management in Japan  Katsuyuki Miura(Shiga University of Medical Science) 
±³À°½Ã°£ 11-04 Rooom A 15:45~16:00 Trends of Hypertension Prevalence and Management in Korea  ÀÌÈ£±Ô(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-04 Rooom A 16:00~16:15 ÆгΠÅäÀÇ  ÀÌÁÖ¹Ì, ÀÌÇõÈñ, Á¶¼Ò¹Ì(À»ÁöÀÇ´ë, ¿¬¼¼ÀÇ´ë, Cardiovascular Disease Initiative) 
±³À°½Ã°£ 11-04 Rooom A 16:25~16:40 Pathophysiological Link between Blood Pressure and Dementia  ¼­»ó¿ø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 16:40~16:55 Impact of Blood Pressure on Cognitive Function  Pedro Guimarães Cunha(University of Minho Guimaraes) 
±³À°½Ã°£ 11-04 Rooom A 16:55~17:10 Recent Evidence of Blood Pressure Variability on Cognition  ±è¿¹¸²(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom A 17:10~17:25 What is the Optimal Strategy to Maintain Cognitive Function for the Patients with Hypertension?  ±èÈñÁø(¼º±Õ°üÀÇ´ë) 
Åä·Ð 11-04 Rooom A 17:25~17:40 ÆгΠÅäÀÇ  ±èÁø±Ç, ¼ÕÀϼ®, ÃÖ¼ºÈÆ, Ç㼺Çõ(¿¬¼¼ÀÇ´ë, °æÈñÀÇ´ë, ÇѸ²ÀÇ´ë, °æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 09:45~10:00 What is Prehypertension? Is It Simply a Precursor State of Hypertension?  ÀÌÈñ¼±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 10:00~10:15 Do All Individuals with Prehypertension Have Similar Risks?  ¹ÚÁø¼±(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 10:15~10:30 How Should We Manage Individuals with Prehypertension? The Role of Exercise  Á¦¼¼¿µ(¼­¿ï½Ã¸³´ë) 
±³À°½Ã°£ 11-04 Rooom B 10:30~10:45 How Should We Manage Individuals with Prehypertension? The Role of Diet Control and Medical Treatment  ±è°æÁø(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 11-04 Rooom B 10:45~11:00 ÆгΠÅäÀÇ  ¾ÈÀ¯¶õ, Á¤¹ÌÇâ, Á¤È¿Áö, ÃÖÀçÇõ(°¡Å縯ÀÇ´ë, °¡Å縯ÀÇ´ë, ¼­¿ï´ëÇб³, ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 11:10~11:25 BP Variability in OSA  ¹è´ëȯ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 11:25~11:40 BP Variability in Dementia  Á¶Á¤¼±(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 11:40~11:55 BP & Heart Rate Variability in ESRD  ±èÇü´ö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 11:55~12:10 Seasonal Variation in Blood Pressure and the Risk of Cardiovascular Diseases  Takayoshi Ohkubo(Teikyo University School of Medicine) 
Åä·Ð 11-04 Rooom B 12:10~12:20 ÆгΠÅäÀÇ  À̸éÈñ, À̼ö¿¬(°¡Å縯ÀÇ´ë, ´Ü±¹ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 12:30~13:10 Effective Strategy for the Treatment of Hypertension  ±è¿ìÇö(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 13:35~13:50 Sarcopenia and Sarcopenic Obesity  ±èÇöÁø(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 13:50~14:05 Improvement of Sodium/Potassium Ratio by Intervention Studies and Cardiovascular Risks  Mari Mori(Mukogawa Women¡¯s University) 
±³À°½Ã°£ 11-04 Rooom B 14:05~14:20 Sarcopenia and Arterial Stiffness  ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 14:20~14:35 Sarcopenia and CAD/Stroke/Renal Disease  ¼Û¿µ¸²(ÇѸ²ÀÇ´ë) 
Åä·Ð 11-04 Rooom B 14:35~14:50 ÆгΠÅäÀÇ  ¼­¿ø¿ì, ¼­Àçºó, À̹ÎÈ£, Á¶»óÈ£(ÇѸ²ÀÇ´ë, ¼­¿ïÀÇ´ë, ¼øõÇâÀÇ´ë, ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 15:00~15:15 Prevalence of Adolescent Essential Hypertension and Tracking of Blood Pressure from Childhood to Adulthood  ±è¼ºÇý(Â÷ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 15:15~15:30 Effect of Screening for Hypertension in Children and Adolescents on Adult Hypertension  ¹Ú¼¼Áø(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 15:30~15:45 Clinical Trials on Adolescent Essential Hypertension and Their Outcome  ½ÅÀçÀÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 15:45~16:00 Pathophysiology of Obesity-Induced Hypertension in Adolescents  Á¤¼¼¿ë(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-04 Rooom B 16:00~16:15 ÆгΠÅäÀÇ  ±èÁöÈ«, ±èÇý¼ø, Çѹ̿µ(¿¬¼¼ÀÇ´ë, ÀÌÈ­ÀÇ´ë, °æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 16:25~16:40 Nocturnal Hypertension and Heart Failure  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 16:40~16:55 Measures of Hemodynamic Burden on Incidence HF: Brachial versus Central  ±èÁöÈñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 16:55~17:10 Management of Hypotension in Patients with Heart Failure  Á¶À翵(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom B 17:10~17:25 Clinical Importance of Urinary Sodium Excretion in Acute Heart Failure  À§Áø(°¡ÃµÀÇ´ë) 
Åä·Ð 11-04 Rooom B 17:25~17:40 ÆгΠÅäÀÇ  °ø¹Î±Ô, ±è¹Î°ü, ±è¿ìÇö, ÇöÁØÈ£(¼øõÇâÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÇѾçÀÇ´ë, ¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 09:45~10:05 New Biomarker for Vascular Inflammation: Hormonal Regulation of APE1/Ref-1  Àüº´È­(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 10:05~10:25 Immunity and Salt-Sensitivity in Hypertension  ±èÀΰâ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 10:25~10:45 Potassium Intake, Blood Pressure Variability and Cardiovascular Outcomes in Chronic Kidney Disease  ¼­»óÇå(Àü³²ÀÇ´ë) 
Åä·Ð 11-04 Rooom C 10:45~11:00 ÆгΠÅäÀÇ  ¹èÀºÈñ, ÀÌ»óÈ£, Áø¼±¾Æ(Àü³²ÀÇ´ë, °æÈñÀÇ´ë, Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 11:10~11:25 Effect of perindopril as the initial first-line treatment for patients with hypertension  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 11:45~12:00 Achieving target blood pressure with triple-combination therapy, Dukarb Plus  ¼ÕÀϼ®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 12:00~12:15 Dulaglutide exerts beneficial effects of ASCVD with Type 2 diabetes  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 12:30~13:10 Combination therapy of antihypertensive drugs for CV protection  ±è¿ø(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 13:35~13:50 Tactics for Early Diagnosis of Pulmonary Hypertension  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 13:50~14:05 Tactics for Medical Management of Pulmonary Hypertension  ±è°æÈñ(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-04 Rooom C 14:05~14:20 Tactics for Invasive Management of Pulmonary Hypertension  ÀÌ»óÀ±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 14:20~14:35 Tactics of Lung Transplantation for Pulmonary Hypertension  ÀÌÁø±¸(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-04 Rooom C 14:35~14:50 ÆгΠÅäÀÇ  ±è°èÈÆ, ³ª½Â¿ø, ³ªÁø¿À, ÀüÂùÈï(Àü³²ÀÇ´ë, ¿ï»êÀÇ´ë, °í·ÁÀÇ´ë, ¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 15:00~15:15 Challenges of Clinical Hypertension (CH)  Á¤¿íÁø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 15:15~15:30 Tips and Supports from the Forerunner, KCJ  Ã¤ÀÎÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 15:30~15:45 Tips and Supports from the Forerunner, KJIM  ÃÖ¹ü¼ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 15:45~16:00 For Better Tomorrow of Clinical Hypertension  Çã¼±(ÇѸ²ÀÇ´ë) 
Åä·Ð 11-04 Rooom C 16:00~16:15 ÆгΠÅäÀÇ  ±èÁöÈñ, ¹ÚÀçÇü, Á¶ÇöÀç(°¡Å縯ÀÇ´ë, Ãæ³²ÀÇ´ë, ¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 16:25~16:50 °íÇ÷¾Ð ȯÀÚ¿¡¼­ÀÇ ÁÖ¿ä ¾àÁ¦ ºÎÀÛ¿ë°ú ´ëó ¹æÇâ  Á¶Àͼº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 16:50~17:15 °íÇ÷¾Ð ȯÀÚÀÇ °ü¸®Áß ÈçÈ÷ ¸¸³ª´Â Áú¹®°ú ´ëó ¹æÇâ  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom C 17:15~17:40 °íÇ÷¾Ð ȯÀÚ °ü¸® Update  ¹ÚÂù¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 09:45~10:00 Pulsatile Hemodynamics and Coronary Artery Disease  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 10:00~10:15 Arterial Stiffness and Cerebral Small Vessel Disease  ¹Ú±¤¿­(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 10:15~10:30 Prognostic Value of Arterial Stiffness in Menopausal Women  ±è¹Î°ü(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 10:30~10:45 The Role of Arterial Stiffness in CKD  ±èÈ¿Áø(ºÎ»êÀÇ´ë) 
Åä·Ð 11-04 Rooom D 10:45~11:00 ÆгΠÅäÀÇ  ¹®Àαâ, ¹ÚÇö¿õ, ¾È°èÅÃ, ÀÌÁ¤È¯(¼øõÇâÀÇ´ë, Ãæ³²ÀÇ´ë, Ãæ³²ÀÇ´ë, ¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 11:10~11:35 Comprehensive CV risk management for hypertension patients with multiple risk factors  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 11:50~12:20 Industrial Symposium IV  ÁÖ½ÂÀç(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 12:30~12:50 °íÇ÷¾Ð ÇÕº´Áõ °ü¸®¿¡¼­ ·Î»ç¸£ÅºÀÇ ¿ªÇÒ  Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 12:50~13:10 The recent trend in managing dyslipidemia focused on intensive & combination therapy  ±èº´±Ô(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 13:35~13:50 Pathophysiology of Preeclampsia  Á¶ÀÎÁ¤(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 13:50~14:05 Long-Term Cardiovascular Disease Risk in Women after Hypertensive Disorders of Pregnancy  ¼³»óÈÆ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 14:05~14:20 Threshold and Target Blood Pressure for Drug Therapy in Hypertensive Disorders of Pregnancy  ¾çµ¿Çå(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 14:20~14:35 Pulmonary Hypertension in Pregnancy  ±èÇý¹Ì(Áß¾ÓÀÇ´ë) 
Åä·Ð 11-04 Rooom D 14:35~14:50 ÆгΠÅäÀÇ  ±èºÀÁØ, ÀÓ°æÈñ, Á¤Çý¹®(°í½ÅÀÇ´ë, µ¿¾ÆÀÇ´ë, °æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 15:00~15:15 OSA, is One of the Risk Factors or Comorbidities for Hypertension?  ³ªÁø¿À(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 15:15~15:30 How about the Diurnal Pattern of Blood Pressure in Hypertensive Patients with OSA?  ¹Ú»ó¹Î(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 15:30~15:45 How to Treat the Hypertensive Patients with OSA: Combined CAPA and Antihypertensive Drug is Helpful?  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 15:45~16:00 Dedicated OSA Treatment Can Improve the Clinical Outcomes in Hypertensive Patients with OSA?  ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-04 Rooom D 16:00~16:15 ÆгΠÅäÀÇ  ±è±¤½Ç, ±è¼ºÇØ, ±èÇзÉ, ÀÌÁÖÈñ(ÀÎÁ¦ÀÇ´ë, °Ç±¹ÀÇ´ë, ¼­¿ïÀÇ´ë, ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 16:25~16:40 Beta Blocker for AF and HTN  À̼ҷÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 16:40~16:55 Contribution of AF Burden for Future Heart Failure and Stroke Events  ±èÁø¹è(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 16:55~17:10 Strategies of Rhythm Control in Elderly Patients with AF and HTN  ½ÉÀç¹Î(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-04 Rooom D 17:10~17:25 Strategies of Anticoagulation in Elderly Patients with AF and HTN  ¾çÇʼº(Â÷ÀÇ´ë) 
Åä·Ð 11-04 Rooom D 17:25~17:40 ÆгΠÅäÀÇ  ¹ÚÁعü, ¹ÚÁø±Ô, ÀÌ»óÀº, ÀÌÁ¤¸í(ÀÌÈ­ÀÇ´ë, ÇѾçÀÇ´ë, ÀÌÈ­ÀÇ´ë, °æÈñÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-11-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ´ë±¸°æºÏÁöȸ Ãß°èÇÐȸ ¼Ò¾Æû¼Ò³â°ú ¼±»ý´ÔµéÀÇ 1Â÷Áø·á¸¦ À§ÇÑ ¿¬¼ö±³À° : 2022-11-05
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ)11¿ù4ÀÏ À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ(µÎ°æºÎ ¼ö¼ú ÈÄ Ã¢»ó°ü¸®) : 2022-11-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 12 2024-06-14
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 14 2024-06-14
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 16 2024-06-14
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 10 2024-06-14
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 9 2024-06-14
20983 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 5 2024-06-14
20982 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 9 2024-06-14
20981 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 10 2024-06-14
20980 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 6 2024-06-14
20979 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 5 2024-06-14
20978 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 6 2024-06-14
20977 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 5 2024-06-14
20976 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 13 2024-06-14
20975 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 4 2024-06-14
20974 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 3 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷